Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bioretec Oy
BRETECCurrent price
2.01 EUR
+0.14 EUR (+7.49%)
Last closed
1.88 EUR
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Medical Devices
Exchange
Helsinki Exchange
Capitalization
43 286 195 EUR
Yield for 12 month
-17.62 %
1Y
3Y
5Y
10Y
15Y
BRETEC
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. Bioretec Ltd. was incorporated in 1998 and is headquartered in Tampere, Finland. Address: Yrittäjänkulma 5, Tampere, Finland, 33710
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.76 EURP/E ratio
–Dividend Yield
–Current Year
+2 926 081 EUR
Last Year
+1 992 113 EUR
Current Quarter
+1 880 807 EUR
Last Quarter
+1 511 747 EUR
Current Year
+2 123 700 EUR
Last Year
+1 367 797 EUR
Current Quarter
+1 319 846 EUR
Last Quarter
+1 246 017 EUR
Key Figures BRETEC
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
–
PEG Ratio
–
Return On Equity TTM
-4861.06 %
Wall Street Target Price
2.76 EUR
Revenue TTM
–
Book Value
–
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.17 EUR
Diluted Eps TTM
-0.17 EUR
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BRETEC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BRETEC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BRETEC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
9.4635
Price Sales TTM
11.1664
Enterprise Value EBITDA
-13.0119
Price Book MRQ
6.2894
Financials BRETEC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BRETEC
For 52 weeks
1.94 EUR
2.99 EUR
50 Day MA
2.56 EUR
Shares Short Prior Month
–
200 Day MA
2.61 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart